Pharmacologic Alteration of Peritoneal Transport Rates

  • Przemyslaw Hirszel
  • John F. Maher


Peritoneal dialysis has become an increasingly popular alternative to hemodialysis for therapy of chronic renal failure [1–3]. Concurrently, the effect of pharmacological and physiological manipulations on peritoneal transport have been explored seeking enhanced understanding of transport mechanisms and clinically useful methods to augment transport.


Peritoneal Dialysis Continuous Ambulatory Peritoneal Dialysis Ultrafiltration Rate Peritoneal Dialysis Solution Mesenteric Blood Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Broyer M, Brunner FP, Brynger H, Donckerwolcke RA, Jacobs C, Kramer P, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe, XII, 1981. Proc Eur Dial Transplant Assoc 19: 3, 1982.Google Scholar
  2. 2.
    Oreopoulos DG: Chronic peritoneal dialysis. Clin Nephrol 9: 165, 1978.PubMedGoogle Scholar
  3. 3.
    Nolph KD: Continuous ambulatory peritoneal dialysis. Am J Nephrol 1: 1, 1981.PubMedGoogle Scholar
  4. 4.
    Verger C, Brunschvicg O, Le Charpentier Y, Lavergne A, Vantelon J: Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis. Proc Eur Dial Transpl Assoc 18: 199, 1981.Google Scholar
  5. 5.
    Nolph KD, Stoltz ML, Maher JF: Altered peritoneal permeability in patients with systemic vasculitis. Ann Intern Med 75: 753, 1973.Google Scholar
  6. 6.
    Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK: Continuous ambulatory peritoneal dialysis. Ann Intern Med 88: 449, 1978.PubMedGoogle Scholar
  7. 7.
    Nolph KD, Miller FN, Pyle WK, Popovich RP, Sorkin MI: An hypothesis to explain the ultrafiltration characteristics of peritoneal dialysis. Kidney Int 20: 543, 1981.PubMedGoogle Scholar
  8. 8.
    Hirszel P, Dodge K, Maher JF: Acceleration of peritoneal solute transport by cytochalasin D. Uremia Invest 8: 85, 1985.Google Scholar
  9. 9.
    Maher JF, Hirszel P, Bennett RR, Chakrabarti E: Amphotericin B selectively increases peritoneal ultrafiltration. Am J Kidney Dis 4: 285, 1984.PubMedGoogle Scholar
  10. 10.
    Maher JF, Hirszel P, Hohnadel DC, Abraham J, Lasrich M: Fatty acid removal during peritoneal dialysis. Mechanisms, rates and significance, asaio J 1: 8, 1978.Google Scholar
  11. 11.
    Dedrick RL, Myers CE, Bungay PM, DeVita VT Jr: Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62: 1, 1978.PubMedGoogle Scholar
  12. 12.
    Henderson LW, Cheung AK, Chenoweth DE: Choosing a membrane. Am J Kidney Dis 3: 5, 1983.PubMedGoogle Scholar
  13. 13.
    Garred LJ, Canaud B, Farrell PC: A simple kinetic model for assessing peritoneal mass transfer in chronic ambulatory peritoneal dialysis, asaio J 6: 131, 1983.Google Scholar
  14. 14.
    Pappenheimer JR, Renkin EM, Borrero LM: Filtration, diffusion and molecular sieving through peripheral capillaries; a contribution to the pore theory of capillary permeability. Am J Physiol 167: 13, 1951.PubMedGoogle Scholar
  15. 15.
    Lasrich M, Maher JM, Hirszel P, Maher JF: Correlation of peritoneal transport rates with molecular weight: a method for predicting clearances, asaio J 2: 107, 1979.Google Scholar
  16. 16.
    Gosselin RE, Berndt WO: Diffusional transport of solutes through mesentery and peritoneum. J Theor Biol 3: 487, 1962.Google Scholar
  17. 17.
    Aune S: Transperitoneal exchange II: Peritoneal blood flow estimated by hydrogen gas clearances. Scand J Gastroenterol 5: 99, 1970.PubMedGoogle Scholar
  18. 18.
    Nolph KD: The first hemodialyzer. asaio J 1: 2, 1978.Google Scholar
  19. 19.
    Hirszel P, Chakrabarti EK, Bennett RR, Maher JF: Perm-selectivity of peritoneum to neutral dextrans. Trans Am Soc Artif Intern Organs 30: 625, 1984.PubMedGoogle Scholar
  20. 20.
    Casley-Smith JR: An electron microscopical study of the passage of ions through the endothelium of lymphatic and blood capillaries and through the mesothelium. Q J Exp Physiol 52: 105, 1967.Google Scholar
  21. 21.
    Cotran RS, Karnovsky MJ: Ultrastructural studies of the permeability ol the mesothelium to horseradish peroxidase. J Cell Biol 57: 123, 1968.Google Scholar
  22. 22.
    Gotloib L, Digenes GE, Rabinovich S, Medline A, Oreopoulos DG: Ultrastructure of normal rabbit mesentery. Nephron 34: 248,1983.PubMedGoogle Scholar
  23. 23.
    Wayland H: Transmural and interstitial molecular transport. In: Legrain M (ed), Proc Int Symposium Continuous Am-bulatory Peritoneal Dialysis, Excerpta Medica, Amsterdam, p 18, 1980.Google Scholar
  24. 24.
    Breborowicz A, Knapowski J: Studies on the resistance of the peritoneal mesothelium to solute transport. Peritoneal Dial Bull 4: 37, 1984.Google Scholar
  25. 25.
    Cascarano J, Rubin AD, Chick WL, Zweifach BW: Meta-bolically induced permeability changes across mesothelium and endothelium. Am J Physiol 206: 373, 1964.PubMedGoogle Scholar
  26. 26.
    Robson, M, Oreopoulos DG, Izatt S, Ogilvie R, Rapaport A, deVeber GA: Influence of exchange volume and dialysate flow rate on solute clearance in peritoneal dialysis. Kidney Int 14: 486, 1978.PubMedGoogle Scholar
  27. 27.
    Twardowski Z, Nolph KD, Prowant BF, Moore HL: Efficiency of high volume low frequency continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 29: 53, 1983.PubMedGoogle Scholar
  28. 28.
    Ratnu KS, Haldia KR, Panicker S, Mathur AS: A new technique ― semicontinuous rapid flow, high volume exchange for effective peritoneal dialysis in shorter periods. Nephron 31: 159, 1982.PubMedGoogle Scholar
  29. 29.
    Diaz-Buxo JA, Walker PJ, Farmer CD, Chandler JT, Holt KL, Cox P: Continuous cyclic peritoneal dialysis. Trans Am Soc Artif Intern Organs 27: 51, 1981.PubMedGoogle Scholar
  30. 30.
    Nakagawa D, Price C, Steinbaugh B, Suki W: Continuous cycling peritoneal dialysis: a viable option in the treatment of chronic renal failure. Trans Am Soc Artif Intern Organs 23:55, 1981.Google Scholar
  31. 31.
    Grayson J, Mendel D: Physiology of the Splanchnic Circulation. Williams and Wilkins Co, Baltimore, 1965.Google Scholar
  32. 32.
    Lanciault G, Jacobson ED: The gastrointestinal circulation. Gastroentereology 71: 851, 1976.Google Scholar
  33. 33.
    Felt, J, Richard C, McCaffrey C, Levy M: Peritoneal clearance of creatinine and inulin during dialysis in dogs: effect of splanchnic vasodilators. Kidney Int 17: 459, 1979.Google Scholar
  34. 34.
    Renkin EM: Exchange of substances through capillary walls. In: Wolstenholme GEW (ed), Ciba Foundation Symposium, Little, Brown and Co, Boston, p 50, 1969.Google Scholar
  35. 35.
    Swan KG, Reynolds DG: Adrenergic mechanisms in the canine mesenteric circulation. Am J Physiol 220: 1779, 1971.PubMedGoogle Scholar
  36. 36.
    Messina EJ, Weiner R, Kaley G: Prostaglandins and local circulatory control. Fed Proc 35: 2367, 1976.PubMedGoogle Scholar
  37. 37.
    Steinhauer HB, Gunter B, Schollmeyer P: Enhanced peritoneal generation of vasoactive prostaglandins during peritonitis in patients undergoing CAPD. In: Maher JF, Winchester JF (eds), Frontiers in Peritoneal Dialysis, Field, Rich and Assoc, New York, p 604, 1986.Google Scholar
  38. 38.
    Maher JF: Blood flow to the peritoneum: physiological and pharmacological influences. In: Moncrief JW, Popovich RP (eds), CAPD Update Continuous Ambulatory Peritoneal Dialysis, Masson Pubi USA, New York, p 53, 1981.Google Scholar
  39. 39.
    Courtice FC, Roberts DCK: Peritoneal fluid in the rabbit: permeability of the mesothelium to proteins, lipoproteins and acid hydrolases. Lymphology 8:1, 1975.PubMedGoogle Scholar
  40. 40.
    Torres IJ, Litterst CL, Guarino AM: Transport of model compounds across the peritoneal membrane in the rat. Pharmacology 17: 330, 1978.PubMedGoogle Scholar
  41. 41.
    Richardson PDI: The actions of natural secretin on the small intestinal vasculature of the anesthetized cat. Br J Pharmacol 58: 127, 1976.PubMedGoogle Scholar
  42. 42.
    Goldberg LI: Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 24: 1, 1972.PubMedGoogle Scholar
  43. 43.
    Henderson LW, Nolph KD: Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis. J Clin Inves 48: 992, 1969.Google Scholar
  44. 44.
    Maher JF, Bennett RR, Hirszel P, Chakrabarti E: The mechanism of dextrose-enhanced peritoneal mass transport rates. Kidney Int 28: 16, 1985.PubMedGoogle Scholar
  45. 45.
    Harris EJ: Transport and Accumulation in Biological Systems, Third Edition. Butterworths, London, 1972.Google Scholar
  46. 46.
    Charonis AS, Wissig SL: Anionic sites in basement membranes. Differences in their electrostatic properties in continuous and fenestrated capillaries. Microvasc Res 25: 265, 1983.PubMedGoogle Scholar
  47. 47.
    Gotloib L, Shustack A, Jaichenko J: Ruthenium-red-stained anionic charges of rat and mice mesothelial cells and basal lamina: The peritoneum is a negatively charged dialyzing membrane. Nephron 48: 65, 1988.PubMedGoogle Scholar
  48. 48.
    Leak LV: Distribution of cell surface charges on mesothelium and lymphatic endothelium. Microvasc Res 31: 18, 1986.PubMedGoogle Scholar
  49. 49.
    Ahearn DJ, Nolph KD: Controlled sodium removal with peritoneal dialysis. Trans Am Soc Artif Intern Organs 18: 423,1972.PubMedGoogle Scholar
  50. 50.
    Maher JF, Hohnadel DC, Shea C, DiSanzo F, Cassetta M: Effects of intraperitoneal diuretics on solute transport during hypertonic dialysis. Clin Nephrol 7: 96, 1977.PubMedGoogle Scholar
  51. 51.
    Furman KI, Gomperts ED, Hockley J: Activity of intraperitoneal heparin during peritoneal dialysis. Clin Nephrol 9: 15,1978.PubMedGoogle Scholar
  52. 52.
    Canavese C, Salomone M, Mangiorotti G, Pacitti A, Trucco S, Scaglia C, Assone F, Lunghi F, Vercellone A: Heparin transfer across the rabbit peritoneal membrane. Clin Nephrol 26: 116, 1986.PubMedGoogle Scholar
  53. 53.
    Grahame GR, Torchia MG, Dankewich KA, Ferguson IA: Surface-active material in peritoneal effluent of CAPD patients. Peritoneal Dial Bull 5: 109, 1985.Google Scholar
  54. 54.
    DiPaolo N, Buoncristiani U, Capotundo L, Saggiotti E, DeMia M, Rossi P, Sansoni E, Bernini M: Phosphatidylcholine and peritoneal transport during peritoneal dialysis. Nephron 44: 365, 1986.Google Scholar
  55. 55.
    Breborowicz A, Sombolos K, Rodela H, Ogilvie R, Bargman J, Oreopoulos D: Mechanism of phosphatidylcholine action during peritoneal dialysis. Peritoneal Dial Bull 7: 6, 1987.Google Scholar
  56. 56.
    Mermier P, Baker H: Flux of free fatty acids among host tissues, ascitic fluid and Ehriich ascites carcinoma cells. J Lipid Res 15:339, 1971.Google Scholar
  57. 57.
    Dumont AE, Robbins E, Martelli A, Iliescu H: Platelet blockade of particle absorption from the peritoneal surface of the diaphragm. Proc Soc Exp Biol Med 167: 137, 1981.PubMedGoogle Scholar
  58. 58.
    Flessner MF, Dedrick RL, Fenstermacher JD, Blasberg RG, Sieber SM: Peritoneal absorption of macromolecules. In: Maher JF, Winchester JF (eds), Frontiers in Peritoneal Dialysis, Field Rich and Assoc, New York, p 41, 1986.Google Scholar
  59. 59.
    Daugirdas JT, Ing TS, Gandhi VC, Hano JE, Chen WT, Yan L: Kinetics of peritoneal fluid absorption in patients with chronic renal failure. J Lab Clin Med 95: 351, 1980.PubMedGoogle Scholar
  60. 60.
    Flessner MF, Parker RJ, Sieber SM: Peritoneal lymphatic uptake of fibrinogen and erythrocytes in the rat. Am J Physiol 244: H89, 1983.PubMedGoogle Scholar
  61. 61.
    Rippe B, Stelin G, Ahlmén J: Lymph flow from the peritoneal cavity in CAPD patients. In: Maher JF, Winchester JF (eds), Frontiers in Peritoneal Dialysis, Field, Rich and Assoc, New York, p 24, 1986.Google Scholar
  62. 62.
    Mactier RA, Nolph KD, Khanna R, Twardowski ZJ, Moore H, McGary T: Lymphatic absorption in peritoneal dialysis in the rat. Lymphology 20: 47, 1987.Google Scholar
  63. 63.
    Hirszel P, Shea-Donohue T, Chakrabarti E, Montcalm E, Maher JF: The role of the capillary wall in restricting diffusion of macromolecules. A study of peritoneal clearance of dextrans. Nephron 1988 49: 58, 1988.Google Scholar
  64. 64.
    Khanna R, Mactier R, Twardowski ZJ, Nolph KD: Peritoneal cavity lymphatics. Peritoneal Dial Bull 6: 113, 1986.Google Scholar
  65. 65.
    Mactier RA, Khanna R, Nolph KD, Twardowski ZJ, Moore H: Neostigmine increases ultrafiltration and solute clearances in peritoneal dialysis by reducing lymphatic drainage. Peritoneal Dial Bull 7: S50, 1987.Google Scholar
  66. 66.
    Mactier R, Khanna R, Moore H, Twardowski Z, Nolph K: Phosphatidylcholine enhances the efficiency of peritoneal dialysis by reducing lymphatic reabsorption. Abstracts Am Soc Nephrol 20: 100A, 1987.Google Scholar
  67. 67.
    Miller FN, Joshua IG, Harris PD, Wiegman DL, Jauchem JR: Peritoneal dialysis solutions and the microcirculation. Contrib Nephrol 17:51, 1979.PubMedGoogle Scholar
  68. 68.
    Nolph KD: Peritoneal anatomy and transport physiology. In: Drukker W, Parsons FM, Maher JF (eds), Replacement of Renal Function by Dialysis, Second edition, Martinus Nijhoff, The Hague, p 440, 1983.Google Scholar
  69. 69.
    Breborowicz A, Knapowski J: Local anesthetic-bupivicaine increases the transperitoneal transport of solutes. Part II: In vitro study. Peritoneal Dial Bull 4: 224, 1984.Google Scholar
  70. 70.
    McGary TJ, Nolph KD, Moore HL, Kartinos NJ: Polycation as an alternative osmotic agent and phosphate binder in peritoneal dialysis. Uremia Invest 8: 79, 1984.PubMedGoogle Scholar
  71. 71.
    DeSanto NG, Capodicasa G, Capasso G, Giordano C: Development of means to augment peritoneal urea clearances: The synergistic effects of combining high dialysate temperature and high dialysate flow rates with dextrose and nitroprusside. Artif Organs 5: 409, 1981.Google Scholar
  72. 72.
    Erbe RW, Green JA Jr, Weller JM: Peritoneal dialysis during hemorrhagic shock. J Appi Physiol 22: 131, 1967.Google Scholar
  73. 73.
    Greene JA Jr, Lapco L, Weller JM: Effect of drug therapy of hemorrhagic hypotension on kinetics of peritoneal dialysis in the dog. Nephron 7: 178, 1970.PubMedGoogle Scholar
  74. 74.
    Kincaid-Smith P: Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions. Kidney Int 7: 242, 1975.PubMedGoogle Scholar
  75. 75.
    Maher JF, Hirszel P: Augmentation of peritoneal clearances by drugs. In: Legrain M (ed), Proc Int Symposium Continuous Ambulatory Peritoneal Dialysis, Excerpta Med, Amsterdam, p42, 1980.Google Scholar
  76. 76.
    Maher JF, Hirszel P, Abraham JE, Galen MA, Chamberlin M, Hohnadel DC: The effect of dipyridamole on peritoneal mass transport. Trans Am Soc Artif Intern Organs 23: 219, 1977.PubMedGoogle Scholar
  77. 77.
    Brown ST, Ahearn DJ, Nolph KD: Reduced peritoneal clearance in scleroderma increased by intraperitoneal isoproterenol. Ann Intern Med 78: 891, 1973.PubMedGoogle Scholar
  78. 78.
    Nolph KD, Miller L, Husted FC, Hirszel P: Peritoneal clearance in scleroderma and diabetes mellitus: effects of intraperitoneal isoproterenol. Int Urol Nephrol 8: 161, 1976.PubMedGoogle Scholar
  79. 79.
    Nolph KD, Ghods AJ, Brown PA, Twardowski ZJ: Effects of intraperitoneal nitroprusside on peritoneal clearance in man with variations of dose, frequency of administration and dwell times. Nephron 24: 114, 1979.PubMedGoogle Scholar
  80. 80.
    Maher JF, Hirszel P, Lasrich M: An experimental model for study of pharmacologic and hormonal influences on peritoneal dialysis. Contrib Nephrol 17: 131, 1979.PubMedGoogle Scholar
  81. 81.
    Gutman RA, Nixon WP, McRae RL, Spencer HW: Effect of intraperitoneal and intravenous vasoactive amines on peritoneal dialysis: study in anephric dogs. Trans Am Soc Artif Intern Organs 22: 570, 1976.PubMedGoogle Scholar
  82. 82.
    Penzotti SC, Mattocks AM: Effects of dwell time, volume of dialysis fluid and added accelerators on peritoneal dialysis of urea. J Pharm Sci 60: 1520, 1971.PubMedGoogle Scholar
  83. 83.
    Maher JF, Hirszel P, Laasrich M: The effects of gastrointestinal hormones on transport by peritoneal dialysis. Kidney Int 16: 130, 1979.PubMedGoogle Scholar
  84. 84.
    Hirszel P, Lasrich M, Maher JF: Divergent effects of catecholamines on peritoneal mass transport. Trans Am Soc Artif Intern Organs 25: 110, 1979.PubMedGoogle Scholar
  85. 85.
    Maher JF, Hirszel P, Lasrich M: Modulation of peritoneal transport rates by prostaglandins. Adv Prostaglandin Thromboxane Res 7: 695, 1980.PubMedGoogle Scholar
  86. 86.
    Nolph KD, Ghods AJ, Van Stone J, Brown PA: The effects of intraperitoneal vasodilators on peritoneal clearances. Trans Am Soc Artif Intern Organs 22: 586, 1976.PubMedGoogle Scholar
  87. 87.
    Maher JF, Shea C, Cassetta M, Hohnadel DC: Isoproterenol enhancement off peritoneal permability. J Dial 1: 319, 1977.PubMedGoogle Scholar
  88. 88.
    Vanichayakornkul S, Nimmanit S, Chirawong P, Nilwarangkur S: Accelerated peritoneal dialysis with intraperitoneal isoproterenol. J Med Assoc Thailand 61 (Suppl 1): 127, 1978.Google Scholar
  89. 89.
    Maher JF, Cassetta M, Shea C, Hohnadel DC: Peritoneal dialysis in rabbits. A study of transperitoneal theophylline flux and peritoneal permeability. Nephron 20: 18, 1978.PubMedGoogle Scholar
  90. 90.
    Londos C, Cooper DMF, Wolff J: Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77: 2551, 1980.PubMedGoogle Scholar
  91. 91.
    Brown EA, Kliger AS, Goffmet J, Finkelstein FO: Effect of hypertonic dialysate and vasodilators on peritoneal dialysis clearances in the rat. Kidney Int 13: 271, 1978.PubMedGoogle Scholar
  92. 92.
    Nolph K, Ghods A, Brown P, Miller F, Harris P, Pyle K, Popovich R: Effects of nitroprusside on peritoneal mass transfer coefficients and microvascular physiology. Trans Am Soc Artif Intern Organs 23: 210, 1977.PubMedGoogle Scholar
  93. 93.
    Hirszel P, Maher JF, Chamberlin M: Augmented peritoneal mass transport with intraperitoneal nitroprusside. J Dial 2: 131, 1978.PubMedGoogle Scholar
  94. 94.
    Raja RM, Kramer MS, Rosenbaum JL: Enhanced clearance with intraperitoneal nitroprusside in high flow recirculation peritoneal dialysis. Trans Am Soc Artif Intern Organs 24: 133,1978.PubMedGoogle Scholar
  95. 95.
    Nolph KD, Ghods AJ, Brown PA, Twardowski PA: Effects of intraperitoneal nitroprusside on peritoneal clearances in man with variations of dose frequency of administration and dwell times. Nephron 24: 114, 1979.PubMedGoogle Scholar
  96. 96.
    Selgas R, Carmona AR, Martinez ME, Perez-Fontan M, Salinas M, Conesa J, Martinez Ara J, Sicilia LS: Peritoneal vascular reserve characterization through nitroprusside-indu-ced modification of peritoneal mass transfer coefficients. Int J Artif Organs 8: 181, 1985.PubMedGoogle Scholar
  97. 97.
    Riembau E, Lloveras J, Aubia J, Masramon J, Garcia C, Orfila MA, Llorach M: Sequential intraperitoneal administration of nitroprusside in patients maintained on peritoneal dialysis. J Dial 4: 203, 1980.Google Scholar
  98. 98.
    Miller FN, Nolph KD, Harris PD, Rubin J, Wiegman DL, Joshua IG, Twardowski ZJ, Ghods AJ: Microvascular and clinical effects of altered peritoneal dialysis solutions. Kidney Int 15: 630, 1979.PubMedGoogle Scholar
  99. 99.
    Sano N, Satoh S, Hashimoto K: Differences among dipyridamole, carbochromen and lidoflazine in responses of the coronary and the renal arteries. Jpn J Pharmacol 22: 857, 1972.PubMedGoogle Scholar
  100. 100.
    Ryckelynck JP, Pierre D, DeMartin A, Rottembourg J: Amelioration des clairances péritonéales par le dipyridamole. Nouv Presse Med 7: 472, 1978.PubMedGoogle Scholar
  101. 101.
    Limido A, Cantu P, Allaria P, Colombo L, Giangrande G: Velocita di flusso ed effetto dei farmaci nella valutazione dell efficienza della dialisi peritoneale. Minerva Nephrol 26: 161, 1979.Google Scholar
  102. 102.
    Rubin J, Adair C, Barnes T, Bower JD: Augmentation of peritoneal clearance by dipyridamole. Kidney Int 22: 658, 1982.PubMedGoogle Scholar
  103. 103.
    Maher JF, Hirszel P: Augmenting peritoneal mass transport. Int J Artif Organs 2: 59, 1979.PubMedGoogle Scholar
  104. 104.
    Reams GP, Young M, Sorkin M, Twardowski Z, Gloor H, Moore H, Nolph KD: Effects of dipyridamole on peritoneal clearances. Uremia Invest 9: 27, 1986.Google Scholar
  105. 105.
    Rubin J, Adair C, Bower J: A double-blind trial of dipyridamole in CAPD. Am J Kidney Dis 5: 262, 1985.PubMedGoogle Scholar
  106. 106.
    Parker HR, Schroeder JP, Henderson LW: Influence of dopamine and Regitine on peritoneal dialysis in unanesthetized dogs. Abstracts Am Soc Artif Intern Organs 7:43, 1978.Google Scholar
  107. 107.
    Chan MK, Varghese Z, Baillod RA, Moorhead JF: Peritoneal dialysis: effect of intraperitoneal dopamine. Dial Transplant 9: 380, 1980.Google Scholar
  108. 108.
    Hirszel P, Lasrich M, Maher JF: Augmentation of peritoneal mass transport by dopamine. Comparison with norepinephrine and evaluation of pharmacologic mechanisms. J Lab Clin Med 94: 747, 1979.PubMedGoogle Scholar
  109. 109.
    Maher JF, DiPaolo B, Shostak A, Hirszel P: Pharmacology of peritoneal transport. In: Khanna R, Nolph DK, Prowant B, Twardowski ZJ, Oreopoulos DG (eds), Advances in Continuous Ambulatory Peritoneal Dialysis, Toronto, Univ Toronto Press, p 3, 1987.Google Scholar
  110. 110.
    Shostak A, Hirszel P, Maher JF: Histamine and antagonists influence peritoneal permeability. Abstracts Am Soc Nephrol 20: 103A, 1987.Google Scholar
  111. 111.
    Maher JF: Principles of dialysis and dialysis of drugs. Am J Med 62: 475, 1977.PubMedGoogle Scholar
  112. 112.
    Lai SM, Nolph KD, Moore HL, Khanna R: Effects of calcium channel blockers (Verapamil, Diltiazem) on peritoneal transport. Trans Am Soc Artif Intern Organs 32: 564, 1986.Google Scholar
  113. 113.
    Lai SM, Moore HL, Nolph KD: Effects of intraperitoneal captopril on peritoneal transport in rats. Peritoneal Dial Bull 7: 80, 1987.Google Scholar
  114. 114.
    Shostak A, Hirszel P, Chakrabarti E, Maher JF: Dihydroergotamine lowers peritoneal transfer rates: A hypovolemic transport decrease. Peritoneal Dial Bull 7: S69, 1987.Google Scholar
  115. 115.
    Pace Asciak CR: Oxidative biotransformation of arachidonic acid. Prostaglandins 13: 811, 1977.PubMedGoogle Scholar
  116. 116.
    Nakano J, McCurdy JR: Hemodynamic effects of prostaglandins El, A1 and F2 in dogs. Proc Soc Exp Biol Med 128: 39, 1968.PubMedGoogle Scholar
  117. 117.
    Messina EJ, Kaley G: Microcirculatory responses to prostacyclin and PGE2 in the rat cremaster muscle. Adv Prostaglandin Thromboxane Res 7: 719, 1980.PubMedGoogle Scholar
  118. 118.
    Vane JR, McGiff JC: Possible contributions of endogenous prostaglandins to the control of blood pressure. Circ Res 36, 37(suppl 1): 68, 1975.Google Scholar
  119. 119.
    Maher JF, Hirszel P, Lasrich M: Prostaglandin effects on peritoneal transport. Proc 2nd Int Symposium on Peritoneal Dial 2: 65, 1981.Google Scholar
  120. 120.
    Mileti M, Bufano G, Scaravonati P, Pecchini F, Carnevale G, Lanzarini P: Effect of indomethacin on the peritoneum of rabbits on peritoneal dialysis. Peritoneal Dial Bull 3: 194, 1983.Google Scholar
  121. 121.
    Strong CG, Romero JC: Effects of indomethacin in rabbit renovascular hypertension. Clin Sci Mol Med 51: 249s, 1976.Google Scholar
  122. 122.
    Hirszel P, Lasrich M, Maher JF: Arachidonic acid increases peritoneal clearances. Trans Am Soc Artif Intern Organs 27: 61, 1981.PubMedGoogle Scholar
  123. 123.
    Thulin L, Samnegârd H: Circulatory effects of gastrointestinal hormones and related peptides. Acta Chir Scand (Suppl) 482: 73, 1978.Google Scholar
  124. 124.
    Fara JW, Rubenstein EH, Sonneschein RR: Intestinal hormones in mesenteric vasodilation after intraduodenal agents. Am J Physiol 223: 1058, 1972.PubMedGoogle Scholar
  125. 125.
    Farah JW: Effects of gastrointestinal hormones on vascular smooth muscle. Am J Dig Dis 20: 346, 1975.Google Scholar
  126. 126.
    Hirszel P, Maher JF, LeGrow W: Increased peritoneal mass transport with glucagon acting at the vascular surface. Trans Am Soc Artif Intern Organs 24: 136, 1978.PubMedGoogle Scholar
  127. 127.
    Farini R, Del Favero G, Adorati M, Pedrazzoli S, Fabris G, Giordano P, D’Angelo A, Zotti E, Lise M, Chiaramonte M, Salvagnini M, Naccarato R: Comparison between bolus injection and infusion of Secretin and Pancreozymin in the diagnosis of chronic pancreatic disease (one-hour test). Acta Hepatogastroenterol (Stuttg) 24: 462, 1977.Google Scholar
  128. 128.
    Biber B, Farah J, Lundgren O: Vascular reactions in the small intestine during vasodilation. Acta Physiol Scand 89: 499, 1973.Google Scholar
  129. 129.
    Hare HG, Valtin H, Gosselin RE: Effect of drugs on peritoneal dialysis in the dog. J Pharmacol Exp Ther 145: 122, 1964.PubMedGoogle Scholar
  130. 130.
    Henderson LW, Kintzel JE: Influence of antidiuretic hormone on peritoneal area and permeability. J Clin Invest 50: 2437, 1971.PubMedGoogle Scholar
  131. 131.
    Shear L, Harvey JD, Barry KG: Peritoneal sodium transport: enhancement by pharmacologic and physical agents. J Lab Clin Med 67: 181, 1966.PubMedGoogle Scholar
  132. 132.
    Maher JF, Hirszel P LeGrow W: Enhanced peritoneal permeability with methyl prednisolone. Clin Res 26: 64A, 1978.Google Scholar
  133. 133.
    Breborowicz A, Knapowski J: Augmentation of peritoneal dialysis clearance with procaine. Kidney Int 26: 392, 1984.PubMedGoogle Scholar
  134. 134.
    Haddy F: The mechanism of potassium vasodilation. In: Vanhoutte PM, Leusen I (eds), Mechanisms of Vasodilation, S Karger, Basel, p 200, 1978.Google Scholar
  135. 135.
    Miller FN, Nolph KD, Joshua IG, Wiegman DL, Harris PD, Anderson DB: Hyperosmolality, acetate and lactate: Dilatory factors during peritoneal dialysis. Kidney Int 20: 397, 1981.PubMedGoogle Scholar
  136. 136.
    Penzotti SC, Mattocks AM: Acceleration of peritoneal dialysis by surface-active agents. J Pharm Sci 57: 1192, 1968.PubMedGoogle Scholar
  137. 137.
    El-Bassiouni EA, Mattocks AM: Acceleration of peritoneal dialysis with minimal N-myristyl-β-amino-proprionate. J Pharm Sci 62L: 1314, 1973.Google Scholar
  138. 138.
    Dunham CB, Hak LJ, Hull JH, Mattocks AM: Enhancement of peritoneal permeability of the rat by intraperitoneal use of docusate sodium. Kidney Int 20: 563, 1981.PubMedGoogle Scholar
  139. 139.
    Maher JF, Chakarabarti E: Ultrafiltration by hyperosmotic peritoneal dialysis fluid excludes intracellular solutes. Am J Nephrol 4: 169, 1984.PubMedGoogle Scholar
  140. 140.
    Raja RM, Kramer MS, Rosenbaum JL, Bolisay C, Krug M: Contrasting changes in solute transport and ultrafiltration with peritonitis in CAPD patients. Trans Am Soc Artif Intern Organs 27: 68, 1981.PubMedGoogle Scholar
  141. 141.
    Alavi N, Lianos E, Van Liew JB, Mookerjee BK, Bentzel CJ: Peritoneal permeability in the rat: Modulation by microfilament-active agents. Kidney Int 27: 411, 1985.PubMedGoogle Scholar
  142. 142.
    Scarpioni L, Ballacchi S, Bergonzi G, Fontana F, Poisetti P, Zanazzi MA: High-dose diuretics in CAPD. Peritoneal Dial Bull 2: 177, 1982.Google Scholar
  143. 143.
    Grzegorzewska A, Baczyk K: Furosemide-induced increase in urinary and peritoneal excretion of uric acid during peritoneal dialysis in patients with chronic uremia. Artif Organs 6: 220, 1982.PubMedGoogle Scholar
  144. 144.
    Bazzato G, Coli U, Landini S, Lucatello S, Fracasso A, Righetto F, Scanferla F, Morachiello P: Restoration of ultrafiltration capacity of peritoneal membrane in patients on CAPD. Int J Artif Organs 7: 93, 1984.PubMedGoogle Scholar
  145. 145.
    Alavi H, Lianos E, Andres G, Bentzel CJ: Effect of protamine on the permeability and structure of rat peritoneum. Kidney Int 21: 44, 1982.PubMedGoogle Scholar
  146. 146.
    Capodicasa G, Capasso G, Anastasio P, Lanzetti N, Giordano C: Changes on peritoneal permeability by charged poly-amino acids. Peritoneal Dial Bull 7: S13, 1987.Google Scholar
  147. 147.
    Breborowicz A, Rodela H, Bargman J, Oreopoulos DG: Effect of cationic molecules on the permeability of the mesothelium in vitro. Peritoneal Dial Bull 7: S9, 1987.Google Scholar
  148. 148.
    Lau AH, Chow Tung E, Assadi FK, Fornell L, John E: Effect of ultrafiltration on peritoneal dialysis drug clearances. Pharmacology 31: 284, 1985.PubMedGoogle Scholar
  149. 149.
    Nolph KD, Nothum RJ, Maher JF: Ultrafiltration: a mechanism for removal of intermediate molecular weight substances in coil dialyzers. Kidney Int 6: 55, 1974.PubMedGoogle Scholar
  150. 150.
    Avasthi PS: Effects of aminonucleoside on rat blood-peritoneal barrier permeability. J Lab Clin Med 94: 295, 1979.PubMedGoogle Scholar
  151. 151.
    Maher JF, Hirszel P, Bennett RR, Chakrabarti E: Augmentation of peritoneal hydraulic permeability by amphotericin B: locus of action. Peritoneal Dial Bull 4: 229, 1984.Google Scholar
  152. 152.
    Indrapasit S, Sooksriwongse C: Effect of chlorpromazine on peritoneal clearances. Nephron 40: 341, 1985.Google Scholar
  153. 153.
    Ronco C, Brendolan A, Bragantini L, Chiaramonte S, Feriani M, Fabris A, LaGreca G: Studies on ultrafiltration in peritoneal dialysis: influence of plasma proteins and capillary blood flow. Peritoneal Dial Bull 6: 93, 1986.Google Scholar
  154. 154.
    Levin TN, Rigden LR, Nielsen LH, Moore HL, Twardowski ZJ, Khanna R, Nolph KD: Maximal ultrafiltration rates during peritoneal dialysis in rats. Kidney Int 31: 731, 1987.PubMedGoogle Scholar
  155. 155.
    Maher JF, Hirszel P, Shostak A, DiPaolo B, Chakrabarti E: Prolonged intraperitoneal dwell decreases ultrafiltration coefficient in rabbits. Am J Kidney Dis 12: 62, 1988.PubMedGoogle Scholar
  156. 156.
    Rubin J, Reed V, Adair C, Bower J, Klein E: Effect of intraperitoneal insulin on solute kinetics in CAPD: insulin kinetics in CAPD. Am J Med Sci 291: 81, 1986.PubMedGoogle Scholar
  157. 157.
    Twardowski ZJ, Khanna R, Nolph KD: Osmotic agents and ultrafiltration in peritoneal dialysis. Nephron 42: 93, 1986.PubMedGoogle Scholar
  158. 158.
    Knochel JP, Clayton LE, Smith WL, Barry KG: Intraperitoneal THAM: an effective method to enhance phénobarbital removal during peritoneal dialysis. J Lab Clin Med 64: 257, 1964.PubMedGoogle Scholar
  159. 159.
    Knochel JP, Mason AD: Effect of alkalinization on peritoneal diffusion of uric acid. Am J Physiol 210: 1160, 1966.PubMedGoogle Scholar
  160. 160.
    Campion DAS, North JDK: Effect of protein binding of barbiturates on their rate of removal during peritoneal dialysis. J Lab Clin Med 66: 549, 1965.PubMedGoogle Scholar
  161. 161.
    Schultz JC, Crouder DG, Medart WS: Excretion studies in ethchlorvynol (Placidyl) intoxication. Arch Intern Med 117: 409, 1966.Google Scholar
  162. 162.
    Etteldorf JN, Dobbins WT, Summit RL, Rainwater WT, Fischer RL: Intermittent peritoneal dialysis using 5% albumin in the treatment of salicylate intoxication in children. J Pediatr 58:226, 1961.PubMedGoogle Scholar
  163. 163.
    Kudla RM, El-Bassiouni EA, Mattocks AM: Accelerated peritoneal dialysis of barbiturates, diphenylhydantoin and salicylate. J Pharm Sci 60: 1065, 1971.PubMedGoogle Scholar
  164. 164.
    Cole DEC, Lirenman DS: Role of albumin enriched peritoneal dialysate in acute copper poisoning. J Pediatr 92: 955, 1978.PubMedGoogle Scholar
  165. 165.
    Mehbod H: Treatment of lead intoxication. Combined use of peritoneal dialysis and edetate calcium disodium. JAMA 201:972, 1967.PubMedGoogle Scholar
  166. 166.
    Lowenthal DT, Chardo F, Reidenberg MM: Removal of mercury by peritoneal dialysis. Arch Intern Med 134: 139, 1974.PubMedGoogle Scholar
  167. 167.
    Falk RJ, Mattern WD, Lamanna RW, Gitelman H J, Parker NC, Cross RE, Rastall JR: Iron removal during continuous ambulatory peritoneal dialysis using desferrioxamine. Kidney Int 24: 110, 1983.PubMedGoogle Scholar
  168. 168.
    Shinaberger JH, Shear L, Clayton LE, Barry KG, Knowlton M, Goldbaum LR: Dialysis for intoxication with lipid soluble drugs: enhancement of glutethimide extraction with lipid dialysate. Trans Am Soc Artif Intern Organs 11: 173, 1965.PubMedGoogle Scholar
  169. 169.
    Maher JF: Characteristics of peritoneal transport: physiological and clinical implications. Mineral Electrolyte Metab 5: 201, 1981.Google Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Przemyslaw Hirszel
  • John F. Maher

There are no affiliations available

Personalised recommendations